CGEM$14.930.67%-0.10
Cullinan Therapeutics Inc (CGEM)
Date: 2026-11-02 16:00O: 15.13H: 15.35L: 14.63C: 14.93Vol: 730.8k
Cullinan Therapeutics Inc stock is traded at $14.93, with a volume of 730,767. It is down -0.67% in the last 24 hours and down -3.74% over the past month. Cullinan Therapeutics Inc is a clinical-stage biopharmaceutical company developing therapies for autoimmune diseases and cancer. Its development pipeline comprises the following drug candidates: CLN-978, a CD19xCD3 bispecific T cell engager that is being developed for autoimmune diseases; CLN-049, a FLT3xCD3 bispecific T cell engager being evaluated in an ongoing clinical trial in patients with relapsed/refractory acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS); Velinotamig, a BCMAxCD3 bispecific T cell engager being developed to counter autoimmune diseases; and Zipalertinib, being developed as a treatment for non-small cell lung cancer. Additionally, the company is developing several preclinical programs in autoimmune diseases and oncology.
Previous Close:
$15.03
Open:
$15.13
24h Volume:
730,767
Relative Volume:
1.36
Market Cap:
$960.82M
Revenue:
$22.39M
Net Income/Loss:
-$221.04M
P/E Ratio:
-
EPS:
-$3.71
Net Cash Flow:
-$178.65M
1W Performance:
+0.61%
1M Performance:
-3.74%
6M Performance:
+11.17%
1Y Performance:
+91.17%
1-Day Range:
$0.00$0.00
1-Week Range:
$14.63$16.19
52-Week Range:
$6.73$23.19
Cullinan Therapeutics Inc Stock (CGEM) Company Profile
Name
Cullinan Therapeutics IncSector
HealthcareIndustry
BiotechnologyPhone
617-410-4650Address
ONE MAIN STREET, CAMBRIDGE, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS
Cullinan Therapeutics Inc Stock (CGEM) Upgrades & Downgrades
Cullinan Therapeutics Inc Stock (CGEM) Financials Data
Cullinan Therapeutics Inc Stock (CGEM) Insider Trading
- Michaelson JenniferSep 08 '26Chief Scientific Officer
- Transaction
- Sale
- Cost
- $21.57
- #Shares
- 8,000
- Value ($)
- 172,560
- #Shares Total
- 158,844
- Michaelson JenniferSep 08 '26Chief Scientific Officer
- Transaction
- Option Exercise
- Cost
- $4.30
- #Shares
- 4,000
- Value ($)
- 17,200
- #Shares Total
- 166,844
- JENNIFER MICHAELSONSep 08 '26Officer
- Transaction
- Proposed Sale
- Cost
- $22.09
- #Shares
- 8,000
- Value ($)
- 176,720
- #Shares Total
- 0
- Michaelson JenniferAug 13 '26Chief Scientific Officer
- Transaction
- Sale
- Cost
- $20.26
- #Shares
- 30,000
- Value ($)
- 607,800
- #Shares Total
- 162,844
- JENNIFER MICHAELSONAug 13 '26Officer
- Transaction
- Proposed Sale
- Cost
- $19.60
- #Shares
- 30,000
- Value ($)
- 588,000
- #Shares Total
- 0
- Michaelson JenniferAug 13 '26Chief Scientific Officer
- Transaction
- Option Exercise
- Cost
- $4.30
- #Shares
- 30,000
- Value ($)
- 129,000
- #Shares Total
- 192,844
- Michaelson JenniferJul 06 '26Chief Scientific Officer
- Transaction
- Option Exercise
- Cost
- $4.30
- #Shares
- 4,000
- Value ($)
- 17,200
- #Shares Total
- 170,844
- JENNIFER MICHAELSONJul 06 '26Officer
- Transaction
- Proposed Sale
- Cost
- $17.63
- #Shares
- 8,000
- Value ($)
- 141,040
- #Shares Total
- 0
- Michaelson JenniferJul 06 '26Chief Scientific Officer
- Transaction
- Sale
- Cost
- $17.82
- #Shares
- 8,000
- Value ($)
- 142,560
- #Shares Total
- 162,844
- Michaelson JenniferMay 05 '26Chief Scientific Officer
- Transaction
- Sale
- Cost
- $14.62
- #Shares
- 8,000
- Value ($)
- 116,996
- #Shares Total
- 166,844
